WHO ICTRP trial
Randomized, double blind, parallel groups, placebo controlled pivotal clinical…
EUCTR2004-003824-36-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2004-003824-36-ES |
|---|---|
| Public title | Randomized, double blind, parallel groups, placebo controlled pivotal clinical trial to asses preliminary efficacy and security of a sublingual Cannabis Standardized Extract (Sativex) added to reference treatment for prevention and treatment of nausea and late vomiting induced by moderately emetogenic chemotherapy. - SATEME-08 |
| Scientific title | Randomized, double blind, parallel groups, placebo controlled pivotal clinical trial to asses preliminary efficacy and security of a sublingual Cannabis Standardized Extract (Sativex) added to reference treatment for prevention and treatment of nausea and late vomiting induced by moderately… |
| Primary sponsor | Fundació Institut Català de Farmacologia |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | Chemotherapy induced nausea and vomiting |
| Interventions | Trade Name: Sativex Product Name: delta9 tetrahidrocannabinol (THC) y cannabidiol (CBD) Product Code: THC CBD Pharmaceutical Form: Sublingual spray INN or Proposed INN: Delta-9-Tetrahidrocannabinol (THC) Concentration unit: mg/ml… |
| Registration date | May 9, 2005 |
| Secondary IDs | SATEME-08 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: